• SENSEX
    NIFTY 50
Business

Merck signs $356 million US supply deal for its experimental COVID-19 treatment

Updated : December 24, 2020 09:34 AM IST

The funding allows for development of MK-7110.
Merck signs $356 million US supply deal for its experimental COVID-19 treatment

You May Also Like

Live TV

recommended for you

Advertisement